---
url: https://www.servicesaustralia.gov.au/breast-cancer
title: Breast cancer - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:40:09.251Z
source: servicesaustralia.gov.au
---
# Breast cancer

The PBS subsidises lapatinib, pertuzumab, trastuzumab, trastuzumab deruxtecan and trastuzumab emtansine for patients with breast cancer.

## on this page

-   [Patient eligibility](#a1)
-   [Section 100 arrangements](#a2)
-   [Authority applications](#a3)
-   [More information](#a4)

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with lapatinib, pertuzumab, trastuzumab, trastuzumab deruxtecan and trastuzumab emtansine under the _National Health Act 1953_, section 85 and section 100 for patients with breast cancer.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home) on the PBS website outlines the restrictions for prescribing lapatinib, pertuzumab, trastuzumab, trastuzumab deruxtecan and trastuzumab emtansine.

## Section 100 arrangements

### Pertuzumab, trastuzumab i.v., trastuzumab deruxtecan and trastuzumab emtansine

These items are only PBS-subsidised for non-admitted patients, day admitted patients, or patients on discharge who are attending:

-   an approved private hospital
-   a public participating hospital
-   a public hospital.

These items aren’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.

## Authority applications

### Trastuzumab

All PBS-subsidised treatment with trastuzumab is Authority Required (Streamlined). You don’t need authority approval from us for the listed quantities and repeats.

### Early HER2 positive breast cancer

#### Applying for initial treatment

Applications for initial authority approval to prescribe PBS-subsidised trastuzumab emtansine to treat early HER2 positive breast cancer can be made either in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [early HER2 positive breast cancer - trastuzumab emtansine - initial authority application form](/pb289?context=20)
-   relevant attachments.

#### Applying for continuing treatment

Applications for continuing authority approval to prescribe PBS-subsidised trastuzumab emtansine to treat early HER2 positive breast cancer can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

### Metastatic (Stage IV) HER2 positive breast cancer

#### Applying for initial treatment

Applications for initial authority approval to prescribe PBS-subsidised lapatinib to treat metastatic (Stage IV) HER2 positive breast cancer can be made either in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [metastatic HER2 positive breast cancer - lapatinib - initial authority application form](/pb099?context=20)
-   relevant attachments.

Applications for initial authority approval to prescribe PBS-subsidised pertuzumab, trastuzumab deruxtecan or trastuzumab emtansine to treat metastatic (Stage IV) HER2 positive breast cancer can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

#### Applying for continuing treatment

Applications for continuing authority approval to prescribe PBS-subsidised pertuzumab, trastuzumab deruxtecan or trastuzumab emtansine to treat metastatic (Stage IV) HER2 positive breast cancer can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

Continuing PBS-subsidised treatment with lapatinib is Authority Required (Streamlined). You don’t need authority approval from us for the listed quantities and repeats.

#### Unresectable and/or metastatic HER2-low breast cancer

Applications for authority approval to prescribe PBS-subsidised trastuzumab deruxtecan to treat unresectable and/or metastatic HER2-low breast cancer can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
